Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma
Clinical trial NCT02335983 · COMPLETED
Trial details
- NCT number
- NCT02335983
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-30
- Primary completion
- 2019-10-28
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.